Polycystic Ovary Syndrome (PCOS)ReferencesCitationsBarbieri RL (2007). Polycystic ovary syndrome. In DC
Dale, DD Federman, eds., ACP Medicine, section 16, chap.
5. New York: WebMD. Speroff L, Fritz MA (2005). Recurrent early pregnancy
loss. In Clinical Gynecologic Endocrinology and
Infertility, 7th ed., pp. 1069–1101. Philadelphia: Lippincott Williams
and Wilkins. Ehrmann DA (2005). Polycystic ovary syndrome.
New England Journal of Medicine, 352(12):
1223–1236. Speroff L, Fritz MA (2005). Anovulation and the
polycystic ovary. Clinical Gynecologic Endocrinology and
Infertility, 7th ed., pp. 465–498. Lippincott Williams and
Wilkins. Huang I, et al. (2007). Endocrine disorders. In JS
Berek, ed., Berek and Novak's Gynecology, 14th ed., pp.
1069–1135. Philadelphia: Lippincott Williams and Wilkins. Elsenbruch S, et al. (2003). Quality of life,
psychological well-being, and sexual satisfaction in women with polycystic
ovary syndrome. Journal of Clinical Endocrinology and
Metabolism, 88(12): 5801–5807. Hunter MH, Sterrett JJ (2000). Polycystic ovary
syndrome: It's not just infertility. American Family
Physician, 62(5): 1079–1088. Lobo RA, Carmina E (2000). The importance of
diagnosing the polycystic ovary syndrome. Annals of Internal
Medicine, 132(12): 989–993. American Association of Clinical Endocrinologists
(2005). Position statement on metabolic and cardiovascular consequences of
polycystic ovary syndrome. Endocrine Practice: 11(2):
126–134. Haas DA, et al. (2003). Effects of metformin on body
mass index, menstrual cyclicity, and ovulation induction in women with
polycystic ovary syndrome. Fertility and Sterility,
79(3): 469–481. American College of Obstetricians and Gynecologists
(2002, reaffirmed 2006). Management of infertility caused by ovulatory
dysfunction. ACOG Practice Bulletin No. 34. Obstetrics and
Gynecology, 99(2): 347–358. Hatcher RA, et al. (2004). Combined (estrogen and
progestin) contraceptives. In A Pocket Guide to Managing
Contraception, pp. 97–119. Tiger, GA: Bridging the Gap
Foundation. Stegmann BJ, et al. (2003). Characteristics predictive
of response to ovarian diathermy in women with polycystic ovarian syndrome.
American Journal of Obstetrics and Gynecology, 188(5):
1171–1173.
Other Works ConsultedAl-Inany H (2006). Polycystic ovary syndrome, search
date October 2005. Online version of BMJ Clinical
Evidence. Available online: http://www.clinicalevidence.com. American College of Obstetricians and Gynecologists
(2002, reaffirmed 2006). Polycystic ovary syndrome. ACOG Practice Bulletin No.
41. Obstetrics and Gynecology, 100(6):
1389–1402. Dronavalli S, Ehrmann DA (2007). Pharmacologic therapy
of polycystic ovary syndrome. Clinical Obstetrics and
Gynecology, 50(1): 244–254. Hall J (2007). Neuroendocrine changes with
reproductive aging in women. Seminars in Reproductive
Medicine, 25(5): 344–351. Hatcher RA, et al. (2005). Combined (estrogen and
progestin) contraceptives. In A Pocket Guide to Managing
Contraception. 2005–2007 ed., pp. 101–123. Tiger, GA: Bridging the Gap
Foundation. Legro RS, et al. (2007). Clomiphene, metformin, or
both for infertility in the polycystic ovary syndrome. New
England Journal of Medicine, 356(6): 551–566. Polycystic Ovary Syndrome
Writing Committee (2005). American Association of Clinical Endocrinologists
position statement on metabolic and cardiovascular consequences of polycystic
ovary syndrome. Endocrine Practice, 11(2):
125–134. Practice Committee of the American Society for
Reproductive Medicine (2006). The evaluation and treatment of androgen excess.
Fertility and Sterility, 86(4, Suppl): S241–S247.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop
Group (2003). Revised 2003 consensus on diagnostic criteria and long-term
health risks related to polycystic ovary syndrome. Fertility
and Sterility, 81(1): 19–25. Setji T, Brown AJ (2007). Polycystic ovary syndrome:
Diagnosis and treatment. American Journal of Medicine,
120(2): 128–132. Thatcher SS (2000). Polycystic Ovary
Syndrome: The Hidden Epidemic. Indianapolis: Perspectives
Press. Thatcher SS, Jackson EM (2006). Pregnancy outcome in
infertile patients with polycystic ovary syndrome who were treated with
metformin. Fertility and Sterility, 85(4):
1002–1009.
Go to previous section | Go to top of page | Go to next section |
| | Author: | Alison Allen Bets Davis, MFA Brenda Vanden Beld, RN, MSN, MBA | Last Updated: April 17, 2008 | | Medical Review: | Anne C. Poinier, MD - Internal Medicine Caroline S. Rhoads, MD - Internal Medicine Deborah A. Penava, BA, MD, FRCSC, MPH - Obstetrics and Gynecology Samuel S. Thatcher, MD, PhD - Obstetrics and Gynecology, Reproductive Endocrinology | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |